Jeff Yass’s Bioceres Crop Solutions BIOX Stock Holding History

Jeff Yass’s Portfolio BIOX Stock Details BIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83,000	Closed	-$379K	–	12666
2025 Q1	$379K	Buy	83,000 +14,600	+21%	+$80.4K	﹤0.01%	9528
2024 Q4	$416K	Buy	+68,400	New	+$467K	﹤0.01%	9125
2024 Q2	–	Sell	-46,000	Closed	-$582K	–	12050
2024 Q1	$582K	Buy	46,000 +7,300	+19%	+$96.1K	﹤0.01%	8138
2023 Q4	$531K	Buy	38,700 +26,200	+210%	+$307K	﹤0.01%	8518
2023 Q3	$141K	Sell	12,500 -8,600	-41%	-$103K	﹤0.01%	10612
2023 Q2	$282K	Buy	21,100 +6,900	+49%	+$80.9K	﹤0.01%	9571
2023 Q1	$165K	Sell	14,200 -10,300	-42%	-$121K	﹤0.01%	10822
2022 Q4	$295K	Sell	24,500 -3,800	-13%	-$49.3K	﹤0.01%	9147
2022 Q3	$368K	Sell	28,300 -20,200	-42%	-$248K	﹤0.01%	9287
2022 Q2	$665K	Buy	48,500 +25,700	+113%	+$341K	﹤0.01%	7564
2022 Q1	$311K	Buy	+22,800	New	+$301K	﹤0.01%	10181

Other funds holding BIOX

Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PCM

Ping Capital Management New York $401M AUM 32.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jeff Yass's BIOX Position: Q2 2026 in Review

Jeff Yass reduced its Bioceres Crop Solutions (BIOX) stake by 1.1% in Q2 2026, selling an estimated $1.16K and leaving 212,930 shares worth $74.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12662.

Jeff Yass first reported a position in BIOX in Q2 2021 and has held it in 10 quarters since. The position peaked at $603K in Q3 2022. 28 funds tracked by Wall St. Rank hold BIOX as of Q2 2026.

Jeff Yass held 212,930 shares of Bioceres Crop Solutions worth $74.5K as of Q2 2026.
Jeff Yass sold 2,462 Bioceres Crop Solutions shares in Q2 2026, an estimated $1.16K.
Bioceres Crop Solutions made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12662 holding.
Jeff Yass first reported a position in Bioceres Crop Solutions in Q2 2021 and has held it in 10 quarters since.
Jeff Yass's Bioceres Crop Solutions position peaked at $603K in Q3 2022.
28 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.